Mylan NV (MYL) Shares Bought by Meeder Asset Management Inc.

Share on StockTwits

Meeder Asset Management Inc. lifted its stake in shares of Mylan NV (NASDAQ:MYL) by 14.6% during the third quarter, HoldingsChannel reports. The firm owned 60,847 shares of the company’s stock after acquiring an additional 7,738 shares during the period. Meeder Asset Management Inc.’s holdings in Mylan were worth $2,227,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the company. James Investment Research Inc. lifted its position in Mylan by 9.5% in the 2nd quarter. James Investment Research Inc. now owns 16,915 shares of the company’s stock valued at $611,000 after acquiring an additional 1,470 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its position in Mylan by 0.7% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 218,314 shares of the company’s stock valued at $7,990,000 after acquiring an additional 1,603 shares in the last quarter. Sumitomo Life Insurance Co. lifted its position in Mylan by 4.1% in the 2nd quarter. Sumitomo Life Insurance Co. now owns 42,775 shares of the company’s stock valued at $1,546,000 after acquiring an additional 1,679 shares in the last quarter. Alerus Financial NA lifted its position in Mylan by 1.6% in the 2nd quarter. Alerus Financial NA now owns 111,011 shares of the company’s stock valued at $4,011,000 after acquiring an additional 1,697 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. lifted its position in Mylan by 8.5% in the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 21,998 shares of the company’s stock valued at $794,000 after acquiring an additional 1,726 shares in the last quarter. 82.99% of the stock is currently owned by institutional investors.

Mylan stock opened at $36.43 on Wednesday. Mylan NV has a 52 week low of $30.33 and a 52 week high of $47.82. The company has a current ratio of 1.29, a quick ratio of 0.77 and a debt-to-equity ratio of 1.18. The company has a market cap of $16.33 billion, a price-to-earnings ratio of 7.99, a PEG ratio of 1.02 and a beta of 1.53.

Mylan (NASDAQ:MYL) last issued its quarterly earnings results on Monday, November 5th. The company reported $1.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.19 by $0.06. Mylan had a net margin of 3.90% and a return on equity of 18.48%. The company had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.91 billion. During the same quarter last year, the business posted $1.10 EPS. Mylan’s quarterly revenue was down 4.2% compared to the same quarter last year. As a group, sell-side analysts expect that Mylan NV will post 4.62 earnings per share for the current fiscal year.

Several research firms have commented on MYL. Wells Fargo & Co reissued a “hold” rating on shares of Mylan in a research report on Thursday, August 2nd. ValuEngine raised shares of Mylan from a “strong sell” rating to a “sell” rating in a research report on Friday, August 3rd. Royal Bank of Canada raised shares of Mylan from a “sector perform” rating to an “outperform” rating and set a $53.00 target price on the stock in a research report on Monday, August 13th. Morgan Stanley cut shares of Mylan from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $46.00 to $36.00 in a research report on Tuesday, October 9th. Finally, Mizuho cut shares of Mylan from a “buy” rating to a “neutral” rating in a research report on Friday, October 5th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and thirteen have assigned a buy rating to the company. Mylan currently has a consensus rating of “Buy” and a consensus target price of $46.87.

COPYRIGHT VIOLATION NOTICE: This article was originally published by Week Herald and is the sole property of of Week Herald. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://weekherald.com/2018/11/07/mylan-nv-myl-shares-bought-by-meeder-asset-management-inc.html.

Mylan Profile

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, brand name, and over-the-counter (OTC) products worldwide. The company operates through three segments: North America, Europe, and Rest of World. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Further Reading: The risks of owning bonds

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan NV (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply